BRIEF-Intellipharmaceutics U.S.-listed shares up 93.1 percent premarket

NEW YORK Tue Nov 19, 2013 7:39am EST

NEW YORK Nov 19 (Reuters) - Intellipharmaceutics International Inc : * U.S.-listed shares up 93.1 percent to $3.65 in premarket; gets final FDA OK to commercially launch 15 and 30 mg generic Focalin XR

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.